Waters Corporation (WAT)
Pre-market:
| Previous close | 313.72 |
| Open | 312.43 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 800 |
| Day's range | 302.50 - 313.36 |
| 52-week range | 231.90 - 363.80 |
| Volume | |
| Avg. volume | 402,569 |
| Market cap | 18.041B |
| Beta (5Y monthly) | 0.96 |
| PE ratio (TTM) | 28.09 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 26 Nov 1996 |
| 1y target est | N/A |
- PR Newswire
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call
Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 4th, 2024, at midnight Eastern Time.
- PR Newswire
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors
Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features. It is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors, saving time lost by investigating the source of fa
- PR Newswire
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges
Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS). To help ensure accuracy and further confidence in test results, Oasis WAX/GCB and GCB/WAX Cartridges are QC-tested by an accredited laboratory for low residual PFAS, to reduce or eliminate any time spent troubleshooting potential assay contamination.
